• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan+
  • Wellness
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Career
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan+
  • Wellness
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Career
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home AI Roundup

Artificial Intelligence Model Matches Patients to Clinical Trials with Near Human Accuracy

byDeepti Shroff Karhade
May 29, 2025
in AI Roundup
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

Key points:
1. TrialGPT, developed by the National Institutes of Health, matches patients to clinical trials with 87.3 percent accuracy
2. Clinicians using TrialGPT screened patients 40 percent faster than manual methods without significant loss in accuracy

Patient recruitment has long been a headache for clinical research but a new tool is turning that around. The National Institutes of Health recently unveiled TrialGPT, an artificial intelligence model designed to streamline how patients are matched to clinical trials. In a large evaluation, TrialGPT achieved an 87.3 percent accuracy rate when compared to expert human reviewers, nearly on par with manual screening which typically lands between 88.7 and 90 percent. The real headline though is that clinicians using TrialGPT completed screenings 40 percent faster. The tool generates keywords for each patient’s medical record and compares them to trial criteria listed on ClinicalTrials.gov, then provides short summaries explaining the match. This helps reduce time spent sifting through endless eligibility forms. However, the system did occasionally misinterpret clinical procedures, underscoring the need for ongoing refinement. Still, with 85 percent of clinical trials facing delays due to recruitment issues, even a partial solution is welcome. The technology is being tested in real world clinical settings through a 2024 Director’s Challenge Innovation Award. Researchers are optimistic that with continued training, the model will only get better. TrialGPT could soon be a key part of how hospitals engage patients in cutting edge research. And for patients with rare or advanced conditions, that means access to experimental treatments they might otherwise miss. Matching the right person to the right study has always been the goal and now artificial intelligence is making it happen faster and smarter than ever before.

Image: PD

©2025 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

RELATED REPORTS

Becton Dickinson Unveils Artificial Intelligence Powered Monitor for Surgery

The Scan by 2 Minute Medicine®: Billy Joel’s Brain Condition, Gigi Robinson’s Surgical Advocacy, Climate and Cancer Risk, and West Nile Virus Reaches the United Kingdom

Artificial Intelligence and Real World Data Speed Up Drug Development

Tags: artificial intelligencehospital careresearchscreening
Previous Post

Physical disability and psychological distress demonstrate marked progression after diagnosis of cancer

RelatedReports

Downward trend in mortality rate for antineutrophil cytoplasmic autoantibody-associated vasculitis
AI Roundup

Becton Dickinson Unveils Artificial Intelligence Powered Monitor for Surgery

May 28, 2025
The Scan by 2 Minute Medicine®:  Ultra-Trail du Mont-Blanc, Taylor Swift, NBA rookie Chet Holmgren and Magic Mushrooms!
The Scan by 2 Minute Medicine®

The Scan by 2 Minute Medicine®: Billy Joel’s Brain Condition, Gigi Robinson’s Surgical Advocacy, Climate and Cancer Risk, and West Nile Virus Reaches the United Kingdom

May 27, 2025
AI Roundup

Artificial Intelligence and Real World Data Speed Up Drug Development

May 27, 2025
FDA-regulated clinical trials rarely report violations
AI Roundup

Food and Drug Administration to Fully Integrate Generative Artificial Intelligence by June

May 26, 2025

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Artificial Intelligence Model Matches Patients to Clinical Trials with Near Human Accuracy
  • Physical disability and psychological distress demonstrate marked progression after diagnosis of cancer
  • Oral gepotidacin is non-inferior to standard therapy for uncomplicated urogenital gonorrhea
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Career
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.